Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Gliosarcoma 2Glioblastoma 2Gallbladder Neoplasms 2Central Nervous System Neoplasms 2Brain Neoplasms 2Bile Duct Neoplasms 2Astrocytoma 2Glioma 1Esophageal Squamous Cell Carcinoma 1Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 7Cisplatin 5Chemotherapy, Adjuvant 3Capecitabine 3pembrolizumab 2Watchful Waiting 2Dihematoporphyrin Ether 2becatecarin 1Tissue Adhesives 1Tegafur 1S 1 (combination) 1Phototherapy 1Photochemotherapy 1Pancreaticojejunostomy 1Oxaliplatin 1Ondansetron 1Leucovorin 1Laser Therapy 1Fluorouracil 1Fentanyl 1Escitalopram 1Enteral Nutrition 1Drug Therapy 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Bile Duct Neoplasms × Dihematoporphyrin Ether × Clear all
NCT00253617 2013-04-04

Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery

National Cancer Institute (NCI)

Phase 3 Withdrawn
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

NCT00513539 2013-02-20

Photostent-02

University College, London

Phase 3 Completed
92 enrolled
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡